Severity
Critical
FDA Drug recall · Reported March 12, 2014
Marketed without an Approved NDA/ANDA; product found to contain dimethazine which is a steroid and/or steroid-like drug ingredient, making it an unapproved new drug
Mira Health Products Ltd. recalled METHA-DROL Extreme capsules, packaged as 60 capsules per bottle Pro-Anabolic Mass Stack D… — a critical-severity action.
METHA-DROL Extreme capsules, packaged as 60 capsules per bottle Pro-Anabolic Mass Stack D… was recalled by Mira Health Products Ltd. in March 12, 2014. Reason: Marketed without an Approved NDA/ANDA; product found to contain dimethazine which is a steroid and/or steroid…. Check the official notice for the remedy. Verify recall #D-1151-2014 with the FDA Drug before acting.
The recall
Mira Health Products Ltd. issued this critical-severity FDA Drug recall — Marketed without an Approved NDA/ANDA; product found to contain dimethazine which is a steroid and/or steroid….
Sourced from official FDA Drug enforcement records. Verify recall #D-1151-2014 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-1151-2014) was formally reported on March 12, 2014, with the manufacturer initiating the action on July 22, 2013. It is classified under Critical severity (Class I), with a current status of Terminated. Mira Health Products Ltd. is listed as the recalling firm, operating out of Farmingdale, NY. Federal records list the affected scope as 5,555 bottles.
The documented reason for this recall is: Marketed without an Approved NDA/ANDA; product found to contain dimethazine which is a steroid and/or steroid-like drug ingredient, making it an unapproved new drug Distribution data in the federal record shows the product reached: Nationwide. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 5 from FDA Drug — clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category — 14,048 drugs & medications recalls on record
Of 100,165 recalls in the database, 23,668 are high severity, 72,097 moderate, and 4,400 low. This recall is classified high severity.
Counts reflect market size and reporting activity, not inherent danger — we do not rank products by risk from raw recall volume.
Severity
Critical
Affected scope
5,555 bottles
Related Recalls
6
5 from same agency
METHA-DROL Extreme capsules, packaged as 60 capsules per bottle Pro-Anabolic Mass Stack Dietary Supplement, Manufactured for Blackstone Labs, Boca Raton, FL
Marketed without an Approved NDA/ANDA; product found to contain dimethazine which is a steroid and/or steroid-like drug ingredient, making it an unapproved new drug
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Critical (Class I) |
| Status | Terminated |
| Recall number | D-1151-2014 |
| Date reported | March 12, 2014 |
| Date initiated | July 22, 2013 |
| Recalling firm | Mira Health Products Ltd. |
| Firm location | Farmingdale, NY |
| Affected scope | 5,555 bottles |
| Distribution | Nationwide |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Keep tracking product safety across the federal recall archive.
Recall Checker
Search the full archive by product name, brand, or recall number across every agency.
Check a product →
FDA Drug recalls
Every recall issued by FDA Drug, newest first.
Browse the feed →
RecallRadar
Live feed of the latest recalls across the FDA, CPSC and NHTSA — filter by agency and severity.
View the live feed →
Rankings
The largest recalls by units affected and the most-recalled product categories.
See the rankings →
Browse by category
Find recalls by product type to spot recurring defect patterns.
All categories →
What to do next
A step-by-step guide to refunds, repairs, and returns after a recall.
Read the guide →
Other recalls in the same product category — useful for spotting patterns across the same defect class or manufacturer.
AVEVA Drug Delivery Systems, Inc. · 2026-06-03
AbbVie Inc. · 2026-06-03
Llorens Pharmaceuticals International Division, Inc. · 2026-05-27
Safecor Health, LLC · 2026-05-27
IntegraDose Compounding Services LLC · 2026-05-27
Compare this recall with Nicotine Transdermal System Patch, 14 mg, 14 patches per bo… →
Source: FDA, CPSC, and NHTSA federal recall databases. This recall: FDA Drug, reported March 12, 2014.
Recall information is sourced from official federal agency databases. Always verify recall details with the issuing agency for the most current status. This information is for research and awareness purposes only.
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records — no number is typed in by an editor. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of June 2026.